0001104659-26-047712
SEC filingQ1 revenue grew 27% to $558M with gross profit up 33% to $275M at 49% margin, but a $3.9B operating loss from goodwill impairment overshadowed core progress amid Mentee Robotics integration.
Revenue increased 27.4% year-over-year to $558 million in Q1 FY2026 from $438 million, reflecting sustained demand for EyeQ solutions following normalization of Tier 1 customer safety stock builds that had shifted orders earlier in prior periods. While supply chain disruptions and component shortages had constrained availability of key EyeQ SoCs previously, these dynamics have largely normalized, though management notes potential for recurring fluctuations in customer ordering and inventory levels that could impact revenue timing.
Gross profit grew 32.9% to $275 million, expanding the margin to 49.3% from prior levels. This improvement stemmed primarily from the lower impact of intangible asset amortization relative to higher revenue, partially offset by elevated EyeQ-related costs per unit due to shifts in product mix. Cost of input materials and manufacturing remain key margin drivers, with ongoing semi-conductor demand contributing to shortages, price increases, and extended lead times that may affect solution pricing and fulfillment.
Operating income deteriorated sharply to a $3.9 billion loss from a $117 million loss, yielding a -698% margin, dominated by a substantial goodwill impairment charge on the Mobileye reporting unit. Net income followed suit at a $3.8 billion loss or $(4.68) diluted EPS, versus $(0.13) last year. These non-cash charges reflect share price declines and integration challenges, underscoring the volatility of acquisition-related accounting.
Net cash from operating activities reached $75 million despite the net loss, supported by non-cash items including the impairment. After $30 million in capital expenditures—up from $14 million prior year—free cash flow stood at $45 million. Investing activities included capex and debt investments, with Mentee Robotics integration demanding significant management attention, capital, and operating expenses, where anticipated benefits may not materialize as expected.
Looking forward, higher expected selling prices for advanced systems should lift gross profit per unit in dollar terms, though equity compensation expenses are set to rise as a core strategy element. Production pricing typically steps down with volume ramps, and residual supply chain risks persist.